drugset / Trial / NCT04262336
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate whether DB-020 administered via an injection in the middle ear prevents hearing loss in participants who will receive high doses of cisplatin as part of their treatment for cancer.
Timeline
- Start
- 2020-02-21
- Primary completion
- 2022-07-30
- Completion
- 2023-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Thiosulfate | Diagnostic / imaging agent | 12 % | Other |
| Comparator | Sodium Thiosulfate | Diagnostic / imaging agent | 25 % | Other |